Delivery Order SPE2DB24D9131-SPE2DB24FXRJ2
Award Date 5/3/24
Potential Completion Date 5/24/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $5,415.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is to provide the specialized drug Xolair 150 mg/mL syringe. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the DLA to place delivery orders for a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $7,737.00, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of DMS Pharmaceutical Group's larger, single-award indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. Under this IDC, the company provides a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,737.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that supports the recurring pharmaceutical supply needs of military health facilities worldwide. Under this contract, DMS Pharmaceutical Group will provide the...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the pharmaceutical product Xolair 150 mg/ml syringe and has an ultimate completion date of March 31, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite-delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
- The Defense Logistics Agency (DLA) awarded a $3,094.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/ml syringes and is not associated with any set-aside designation. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,737.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of Xolair 150 mg/ml syringes and is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/ml syringes and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $20,116.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- SPE2DB24D9131Indefinite Delivery Contract
- SPE2DB24D9131-SPE2DB24FXRJ2Delivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the biologic drug Xolair 150 mg/ml syringes. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract has no set-aside designation.
Generated 8/2/24, 9:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/3/24 |